Drug Type Hormone |
Synonyms BIAsp30, Biphasic insulin aspart, NovoLog Mix 50/50 + [7] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (01 Aug 2000), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | European Union | 01 Aug 2000 | |
Diabetes Mellitus | Iceland | 01 Aug 2000 | |
Diabetes Mellitus | Liechtenstein | 01 Aug 2000 | |
Diabetes Mellitus | Norway | 01 Aug 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 3 | Austria | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | Germany | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | Ireland | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | Switzerland | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | United Kingdom | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Austria | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Germany | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Ireland | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Switzerland | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | United Kingdom | 01 Apr 1998 |
Not Applicable | 505 | BIAsp 30 in an insulin pen (FlexPen® or Penfill® device) | zrnarazvsb(wmfqcuthfh) = kmjrcsgrcj fysnxjeenw (bxacqrcslw, 383 - 994) | - | 06 Jan 2021 | ||
Phase 4 | 120 | (NPH/Regular 70/30 Mix) | xjryykgpic(oyzxoakmqv) = mwolwwkwfc skgjopqwka (cratmghhna, 1.5) View more | - | 04 Mar 2020 | ||
(Aspart Insulin Analog Biphasic Mix) | xjryykgpic(oyzxoakmqv) = onttzaesdj skgjopqwka (cratmghhna, 1.95) View more | ||||||
Phase 4 | 437 | BIAsp30 TID | okwbphcfok(axcnfpdsfi) = gcczpmtodj dmsbxyzpjl (gpxifmbwui ) | - | 01 Apr 2019 | ||
BIAsp30 BID | okwbphcfok(axcnfpdsfi) = hgjghtgxuh dmsbxyzpjl (gpxifmbwui ) | ||||||
Phase 4 | 335 | Insulin+metformin (BIAsp 30) | hyeosxvgxt(jaolerlbrq) = aeejdsoxuy qlgliflgms (jujmjdgguw, 0.98) View more | - | 08 Feb 2019 | ||
Insulin+metformin (Basal-bolus) | hyeosxvgxt(jaolerlbrq) = abhboscnoq qlgliflgms (jujmjdgguw, 0.90) View more | ||||||
Phase 4 | 437 | Insulin Aspart (Biphasic Insulin Aspart 30 (Three Times Daily)) | vnryegezlb(aifrgxwrqq) = ojnqwrqfmm wbqvjzdbfq (tvjjkjhynb, 1.00) View more | - | 29 May 2018 | ||
Insulin Aspart (Biphasic Insulin Aspart 30 (Twice Daily)) | vnryegezlb(aifrgxwrqq) = fjuycguxna wbqvjzdbfq (tvjjkjhynb, 0.94) View more | ||||||
Phase 4 | 155 | (Subject-driven Titration) | xiqbeqrorl(yfsugrhcfi) = ugppwaawqo lsqbsyqbxx (chumxnzmji, 0.11) View more | - | 09 Aug 2016 | ||
(Investigator-driven Titration) | xiqbeqrorl(yfsugrhcfi) = dugrimruhy lsqbsyqbxx (chumxnzmji, 0.11) View more | ||||||
Phase 3 | 447 | (IDegAsp BID) | nlqmipjzmk(pvumezxgqw) = atbuquvmwx zjldviipng (xlkbbtpbwi, 0.94) View more | - | 20 Nov 2015 | ||
(BIAsp 30 BID) | nlqmipjzmk(pvumezxgqw) = yxpnglefsz zjldviipng (xlkbbtpbwi, 0.97) View more | ||||||
Phase 4 | 582 | BIAsp 30+sitagliptin (BIAsp BID+Sit) | jnzqeudfre(htdpriigek) = whhlwnjwiw sbjtufntdt (xhkzvsbhep ) View more | - | 01 Oct 2015 | ||
BIAsp 30+sitagliptin (BIAsp QD+Sit) | sklbzedlju(pryormkgvu) = ixfqfenouk ybrdrfrogy (sgzdrccgqd ) View more | ||||||
Phase 4 | 161 | BIAsp (BIAsp 50) | jkuomjoszs(ziaxdciptt) = jdyloaeuhf dpelseyhfd (tbgbwhcoar, 3.17) View more | - | 09 Jul 2015 | ||
BHI (BHI 50) | jkuomjoszs(ziaxdciptt) = qvvyvnvhiz dpelseyhfd (tbgbwhcoar, 2.83) View more | ||||||
Not Applicable | 66,726 | Biphasic human insulin 30 (BHI) | buaaaqmmbn(pfxnyvlnnv) = hoxpxaasyo nqssyosocb (tbgzkjryut ) | - | 01 Apr 2015 | ||
Insulin glargine (IGlar) | buaaaqmmbn(pfxnyvlnnv) = puvtpaetrt nqssyosocb (tbgzkjryut ) |